Cancer Clinical Studies Service for Assay Optimization and Harmonization

The buyer seeks a vendor to provide cancer clinical studies services for a government authority based in Washington, DC. Required work includes optimizing existing clinical laboratory assays using human specimens for use in clinical trials addressing cancer treatment, prevention, or control. Projects must focus on tumor markers or classifiers ready for future trials and utilize proven or near-approved technologies. The scope also covers lab harmonization, including multi-center studies to standardize protocols and ensure reproducible results across laboratories. Eligibility is restricted to onshore USA organizations only, and the performance of the work will take place offsite. The buyer is currently looking for proposals.